Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 6N35 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6N35 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6N35 | 6N35 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6N35 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6N35 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
| 6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | 6MUB | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MUB | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
| 6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MNF | 6MNF | Anti-HIV-1 Fab 2G12 + Man8 re-refinement | |
| 6N2X | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6N2X | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6N2X | 6N2X | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6N2X | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6N2X | P0DOX7 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | P0DOX7 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 3EYV | 3EYV | Anti-Lewis Y Fab fragment with Lewis Y antigen in the presence of zinc ions | |
| 4HIJ | 4HIJ | Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound L-rhamnose-(1-2)-alpha-D-galactose-(3-O)-phosphate-2-glycerol | |
| 4HII | 4HII | Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound rhamnose-galactose | |
| 4HIH | 4HIH | Anti-Streptococcus pneumoniae 23F Fab 023.102 with bound rhamnose. | |
| 4R0L | 4R0L | Anti-canine CD28 antibody, 1C6, bound canine CD28 | T-cell costimulatory molecule CD28, Antibody 1C6 Heavy chain, Antibody 1C6 Light chain |
| 4R0L | Q9N0N8 | Anti-canine CD28 antibody, 1C6, bound canine CD28 | T-cell costimulatory molecule CD28, Antibody 1C6 Heavy chain, Antibody 1C6 Light chain |
| 6S2I | 6S2I | Anti-tumor antibody 14F7-derived scFv in complex with NeuGc Gm3 | |
| 7KQG | E1TVD5 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQG | 7KQG | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQH | A0A4P8YRB6 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQH | 7KQH | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQI | 7KQI | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQI | A4D5Q0 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7M7W | 7M7W | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape | |
| 7M7W | P0DTC2 | Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape | |
| 3OAU | 3OAU | Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Non-Domain-Exchanged Forms, but only binds the HIV-1 Glycan Shield if Domain-Exchanged | Fab 2G12, heavy chain, Fab 2G12, light chain |
| 7SJ0 | P0DTC2 | Antibody A7V3 bound to N-terminal domain of the spike | |
| 7SJ0 | 7SJ0 | Antibody A7V3 bound to N-terminal domain of the spike | |
| 3VG0 | 3VG0 | Antibody Fab fragment |
